Giverny Capital’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-257
Closed -$19K 56
2024
Q4
$19K Sell
257
-446,031
-100% -$33M ﹤0.01% 62
2024
Q3
$29.5M Buy
446,288
+272
+0.1% +$17.9K 1.12% 28
2024
Q2
$41.2M Buy
446,016
+298
+0.1% +$27.5K 1.74% 23
2024
Q1
$42.6M Buy
445,718
+4,812
+1% +$460K 1.73% 21
2023
Q4
$33.6M Buy
440,906
+304
+0.1% +$23.2K 1.58% 23
2023
Q3
$30.5M Buy
440,602
+706
+0.2% +$48.9K 1.66% 21
2023
Q2
$41.5M Buy
439,896
+24,921
+6% +$2.35M 2.18% 18
2023
Q1
$34.3M Sell
414,975
-11,198
-3% -$926K 2.07% 19
2022
Q4
$31.8M Sell
426,173
-4,023
-0.9% -$300K 1.97% 19
2022
Q3
$35.5M Buy
430,196
+13,314
+3% +$1.1M 2.41% 15
2022
Q2
$39.6M Buy
416,882
+11,791
+3% +$1.12M 2.61% 16
2022
Q1
$47.7M Sell
405,091
-671
-0.2% -$79K 2.69% 16
2021
Q4
$52.6M Buy
405,762
+3,612
+0.9% +$468K 2.8% 15
2021
Q3
$45.5M Sell
402,150
-3,379
-0.8% -$383K 2.71% 17
2021
Q2
$42M Buy
405,529
+15,389
+4% +$1.59M 2.55% 17
2021
Q1
$32.6M Buy
390,140
+2,326
+0.6% +$195K 2.18% 19
2020
Q4
$35.4M Buy
387,814
+14,392
+4% +$1.31M 2.71% 17
2020
Q3
$29.8M Buy
373,422
+795
+0.2% +$63.5K 2.73% 17
2020
Q2
$25.8M Buy
372,627
+17,349
+5% +$1.2M 2.56% 17
2020
Q1
$22.3M Sell
355,278
-30,267
-8% -$1.9M 2.84% 15
2019
Q4
$30M Buy
385,545
+3,846
+1% +$299K 2.71% 16
2019
Q3
$28M Buy
381,699
+729
+0.2% +$53.4K 2.79% 14
2019
Q2
$23.5M Buy
380,970
+9,201
+2% +$567K 2.37% 18
2019
Q1
$23.7M Buy
371,769
+5,235
+1% +$334K 2.72% 15
2018
Q4
$18.7M Sell
366,534
-175,536
-32% -$8.96M 2.47% 16
2018
Q3
$31.5M Buy
542,070
+24,546
+5% +$1.42M 3.56% 11
2018
Q2
$25.1M Buy
517,524
+4,026
+0.8% +$195K 3.27% 12
2018
Q1
$23.9M Buy
513,498
+28,785
+6% +$1.34M 3.2% 13
2017
Q4
$18.2M Buy
+484,713
New +$18.2M 2.5% 19